Hypertension Trial, Recruiting (NCT04707105)

Hypertension Trial, Recruiting NCT04707105 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT04707105 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who are admitted to hospital with a primary intracerebral hemorrhage (bleeding inside the brain that was not caused by another underlying condition).

Who may not be able to join:

People whose brain bleed was caused by another condition, such as a stroke, a burst aneurysm, abnormal blood vessels, a blood clot in a brain vein, a head injury, or a brain tumour.
People whose bleeding is only in the fluid-filled spaces of the brain (isolated intraventricular hemorrhage) or around the surface of the brain (subarachnoid hemorrhage).
People who require surgery to remove the blood clot.
People for whom a full blood sample cannot be collected, or who have a medical reason not to have an MRI scan, or who decline an MRI scan.
People who are not able to attend follow-up appointments for any reason.
People who pass away within 24 hours.
People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Feng Gao, MD,PhD, Second Affiliated Hospital, School of Medicine, Zhejiang University

Phone: 13588451471

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04707105

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 13588451471

More information: https://clinicaltrials.gov/study/NCT04707105

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who are admitted to hospital with a primary intracerebral hemorrhage (bleeding inside the brain that was not caused by another underlying condition).

Who may not be able to join:

People whose brain bleed was caused by another condition, such as a stroke, a burst aneurysm, abnormal blood vessels, a blood clot in a brain vein, a head injury, or a brain tumour.
People whose bleeding is only in the fluid-filled spaces of the brain (isolated intraventricular hemorrhage) or around the surface of the brain (subarachnoid hemorrhage).
People who require surgery to remove the blood clot.
People for whom a full blood sample cannot be collected, or who have a medical reason not to have an MRI scan, or who decline an MRI scan.
People who are not able to attend follow-up appointments for any reason.
People who pass away within 24 hours.
People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Registry

ClinicalTrials.gov

Start date

29 December 2020

Est. completion

1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

proportion of patients with a 3-month modified Rankin Scale (mRS) score≤ 3

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov